DE160447C
(en)
|
|
|
|
|
FI76795C
(en)
|
1979-09-04 |
1988-12-12 |
Bristol Myers Co |
Process for the preparation of novel, therapeutically useful 3,4-disubstituted 1,2,5-thiadiazole-1-oxides and -1,1-dioxides and novel intermediates
|
US4487773A
(en)
|
1981-03-16 |
1984-12-11 |
Mead Johnson & Company |
1,2,4-Triazol-3-one antidepressants
|
IN158869B
(en)
|
1981-03-18 |
1987-02-07 |
Ici Plc |
|
DD160447A1
(en)
|
1981-03-26 |
1983-08-03 |
Johannes Dost |
HERBICIDAL AGENTS CONTAINING 1,2,4-TRIAZOLINONE- (5)
|
EP0067508B1
(en)
|
1981-05-18 |
1985-10-30 |
Imperial Chemical Industries Plc |
Amidine derivatives
|
DE3238590A1
(en)
|
1982-10-19 |
1984-04-19 |
VEB Fahlberg-List Chemische und pharmazeutische Fabriken, DDR 3013 Magdeburg |
Herbicidal agent comprising 1,2,4-triazolin-5-ones
|
NL8204109A
(en)
|
1982-10-25 |
1984-05-16 |
Fahlberg List Veb |
1,2,4-Triazoline-5-one herbicides for galium species - give good control of resistant weeds in cereal and sugar beet e.g. the 3-benzyl-4-para methoxyphenyl cpd.
|
BE894856A
(en)
|
1982-10-28 |
1983-02-14 |
Fahlberg List Veb |
1,2,4-Triazoline-5-one herbicides for galium species - give good control of resistant weeds in cereal and sugar beet e.g. the 3-benzyl-4-para methoxyphenyl cpd.
|
FR2535168B1
(en)
|
1982-10-29 |
1985-08-09 |
Fahlberg List Veb |
HERBICIDE AGENTS BASED ON 1, 2, 4-TRIAZOLINONE 5
|
JPS60215675A
(en)
|
1984-04-09 |
1985-10-29 |
Nippon Nohyaku Co Ltd |
Oxadiazolinone derivative and triazolinone derivative, their preparation, and agent for controlling growth of insect
|
JP2542880B2
(en)
|
1986-12-19 |
1996-10-09 |
メレルダウファーマスーティカルズ インコーポレーテッド |
Use of 5-aryl-3H-1,2,4, -triazol-3-ones as anticonvulsants
|
DE3934081A1
(en)
|
1989-10-12 |
1991-04-18 |
Bayer Ag |
SULFONYLAMINOCARBONYLTRIAZOLINONE
|
EP0500864B1
(en)
|
1990-09-06 |
2001-09-19 |
Pfizer Limited |
Antimuscarinic bronchodilators
|
JP2772875B2
(en)
|
1991-05-14 |
1998-07-09 |
富士写真フイルム株式会社 |
Processing method of silver halide color photographic light-sensitive material and photographic bleach-fixing composition
|
CA2122633C
(en)
|
1991-10-30 |
2003-12-16 |
Ronald Conrad Griffith |
2-heterocyclicethylamine derivatives and their use as pharmaceuticals
|
AU675786B2
(en)
|
1992-04-15 |
1997-02-20 |
Merck Sharp & Dohme Limited |
Azacyclic compounds
|
DE4224929A1
(en)
|
1992-07-28 |
1994-02-03 |
Bayer Ag |
Heterocyclyltriazolinones
|
US5284957A
(en)
|
1992-09-03 |
1994-02-08 |
Eli Lilly And Company |
Excitatory amino acid receptor antagonists
|
IT1256387B
(en)
|
1992-11-13 |
1995-12-04 |
Acraf |
PROCEDURE FOR PREPARING TRIAZOLONI
|
US5783593A
(en)
|
1993-11-04 |
1998-07-21 |
Abbott Laboratories |
Inhibitors of squalene synthetase and protein farnesyltransferase
|
DE4343595A1
(en)
|
1993-12-21 |
1995-06-22 |
Bayer Ag |
Process for the preparation of sulfonylaminocarbonyltriazolinones
|
US5550118A
(en)
|
1994-01-31 |
1996-08-27 |
Eli Lilly And Company |
Polyhydronorharman synthase inhibitors
|
DE4404848A1
(en)
|
1994-02-16 |
1995-08-17 |
Hoechst Ag |
Substituted cyclohexanol esters, their use for the treatment of diseases and pharmaceutical preparations
|
US5464788A
(en)
|
1994-03-24 |
1995-11-07 |
Merck & Co., Inc. |
Tocolytic oxytocin receptor antagonists
|
GB9418545D0
(en)
|
1994-09-15 |
1994-11-02 |
Merck Sharp & Dohme |
Therapeutic agents
|
JPH08157473A
(en)
|
1994-10-06 |
1996-06-18 |
Nissan Chem Ind Ltd |
Pyrazole-based thiazolidines
|
US5641796A
(en)
|
1994-11-01 |
1997-06-24 |
Eli Lilly And Company |
Oral hypoglycemic agents
|
IN183333B
(en)
|
1995-03-15 |
1999-11-20 |
Indian Drugs & Pharma |
|
IL118325A0
(en)
|
1995-05-25 |
1996-10-31 |
Pont Merck And Pharmaceutical |
Integrin receptor antagonists and pharmaceutical compositions containing them
|
DE19521162A1
(en)
|
1995-06-09 |
1996-12-12 |
Bayer Ag |
N-aryl-1,2,4-triazolin-5-one
|
GB9513121D0
(en)
|
1995-06-28 |
1995-08-30 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB9513117D0
(en)
|
1995-06-28 |
1995-08-30 |
Merck Sharp & Dohme |
Therapeutic agents
|
EP0784053A1
(en)
|
1996-01-15 |
1997-07-16 |
Degussa Aktiengesellschaft |
Process for the preparation of triazolinone herbicides
|
DE19601189A1
(en)
|
1996-01-15 |
1997-07-17 |
Degussa |
High yield and economical preparation of 1,2,4-tri:azolin-3(2H)-one(s)
|
JP2000511883A
(en)
|
1996-04-19 |
2000-09-12 |
ノボ ノルディスク アクティーゼルスカブ |
Modulators of molecules with phosphotyrosine recognition units
|
TW467902B
(en)
|
1996-07-31 |
2001-12-11 |
Bristol Myers Squibb Co |
Diphenyl heterocycles as potassium channel modulators
|
ES2267153T3
(en)
|
1996-10-07 |
2007-03-01 |
MERCK SHARP & DOHME LTD. |
NK-1 RECEPTOR ANTAGONISTS OF THE CNS AS ANTIDEPRESSIVE AGENTS AND / OR ANTIANSIEDAD.
|
ES2257771T3
(en)
|
1996-10-28 |
2006-08-01 |
Amersham Health As |
CONTRAST AGENTS.
|
WO1998043962A1
(en)
|
1997-03-28 |
1998-10-08 |
Du Pont Pharmaceuticals Company |
Heterocyclic integrin inhibitor prodrugs
|
AU8242598A
(en)
|
1997-07-18 |
1999-02-10 |
Nippon Kayaku Kabushiki Kaisha |
Aromatic ketone derivatives and uses thereof
|
AU1523199A
(en)
|
1997-11-26 |
1999-06-15 |
Du Pont Pharmaceuticals Company |
1,3,4-thiadiazoles and 1,3,4-oxadiazoles as alphavbeta3 antagonists
|
US7459473B2
(en)
|
1998-06-03 |
2008-12-02 |
Glia Med, Inc. |
N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres
|
US6331537B1
(en)
|
1998-06-03 |
2001-12-18 |
Gpi Nil Holdings, Inc. |
Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
|
WO1999062888A1
(en)
|
1998-06-03 |
1999-12-09 |
Gpi Nil Holdings, Inc. |
Aza-heterocyclic compounds used to treat neurological disorders and hair loss
|
JP2002522494A
(en)
|
1998-08-14 |
2002-07-23 |
ジーピーアイ エヌアイエル ホールディングス, インコーポレイテッド |
N-heterocyclic carboxylic acids and isosteric ureas and carbamates for visual and memory disorders
|
US7265150B1
(en)
|
1998-08-14 |
2007-09-04 |
Gpi Nil Holdings Inc. |
Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds for vision and memory disorders
|
US6339101B1
(en)
|
1998-08-14 |
2002-01-15 |
Gpi Nil Holdings, Inc. |
N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders
|
SE9802937D0
(en)
|
1998-09-01 |
1998-09-01 |
Astra Pharma Prod |
Novel compounds
|
AU1345600A
(en)
|
1998-11-12 |
2000-06-05 |
Merck & Co., Inc. |
Pyrimidinedione derivatives useful as alpha 1a adrenoceptor antagonists
|
FR2793791B1
(en)
|
1999-05-19 |
2002-01-25 |
Univ Paris 7 Denis Diderot |
NOVEL INHIBITOR COMPOUNDS SPECIFIC TO A2 PHOSPHOLIPASES
|
US6455525B1
(en)
|
1999-11-04 |
2002-09-24 |
Cephalon, Inc. |
Heterocyclic substituted pyrazolones
|
DE19955662B4
(en)
|
1999-11-19 |
2011-03-31 |
Arysta LifeScience North America, |
Herbicides based on carbamoyltriazolinone
|
EP1110958A1
(en)
|
1999-12-20 |
2001-06-27 |
Ucb, S.A. |
Alpha-arylethylpiperazine derivatives as neurokinin antagonists
|
AU6594401A
(en)
|
2000-05-24 |
2001-12-03 |
Bayer Aktiengesellschaft |
6-heterocyclyl-3-oxo-3,4-dihydro-quinoxalines
|
US6465456B2
(en)
|
2000-06-29 |
2002-10-15 |
Bristol-Myers Squibb Company |
Isoxazolinone antibacterial agents
|
JO2654B1
(en)
|
2000-09-04 |
2012-06-17 |
شركة جانسين فارماسوتيكا ان. في |
Polyarylcarboxamides useful as lipid lowering agents
|
US6576644B2
(en)
|
2000-09-06 |
2003-06-10 |
Bristol-Myers Squibb Co. |
Quinoline inhibitors of cGMP phosphodiesterase
|
UA82048C2
(en)
*
|
2000-11-10 |
2008-03-11 |
Эли Лилли Энд Компани |
Peroxisome proliferator activated receptor alpha agonists
|
WO2003000682A1
(en)
|
2001-06-25 |
2003-01-03 |
Merck & Co., Inc. |
(pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds
|
JP4299139B2
(en)
|
2001-12-18 |
2009-07-22 |
メルク エンド カムパニー インコーポレーテッド |
Heteroaryl-substituted triazole modulators of metabotropic glutamate receptor-5
|
JP2005521676A
(en)
|
2002-02-07 |
2005-07-21 |
ザ キュレイターズ オブ ザ ユニバーシティ オブ ミズーリ |
Opioid receptor agonist 4- (3-hydroxyphenyl) or 4- (3-alkoxyphenyl) -1,2,4-triazole compounds
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
AU2003276976B2
(en)
|
2002-06-14 |
2009-08-27 |
Syngenta Participations Ag |
Nicotinoyl derivatives as herbicidal compounds
|
AU2003284001A1
(en)
*
|
2002-10-07 |
2004-05-04 |
Bristol-Myers Squibb Company |
Triazolone and triazolethione derivatives
|
US7476743B2
(en)
|
2002-10-11 |
2009-01-13 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
JP2006502230A
(en)
|
2002-10-11 |
2006-01-19 |
サイトキネティクス・インコーポレーテッド |
Compounds, compositions and methods
|
TW200423930A
(en)
|
2003-02-18 |
2004-11-16 |
Hoffmann La Roche |
Non-nucleoside reverse transcriptase inhibitors
|
CN100537564C
(en)
|
2003-04-04 |
2009-09-09 |
麦克公司 |
Di-aryl substituted triazole modulators of metabotropic glutamate receptor-5
|
WO2004089380A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Pharmaceutical use of fused 1,2,4-triazoles
|
UA89035C2
(en)
|
2003-12-03 |
2009-12-25 |
Лео Фарма А/С |
Hydroxamic acid esters and pharmaceutical use thereof
|
WO2005058848A1
(en)
|
2003-12-17 |
2005-06-30 |
Merck & Co., Inc. |
(3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists
|
WO2005077345A1
(en)
|
2004-02-03 |
2005-08-25 |
Astrazeneca Ab |
Compounds for the treatment of gastro-esophageal reflux disease
|
WO2005077178A2
(en)
|
2004-02-16 |
2005-08-25 |
Syngenta Participations Ag |
Herbicidal composition
|
EA200601266A1
(en)
|
2004-02-18 |
2007-02-27 |
Астразенека Аб |
TRIAZOLE COMPOUNDS AND THEIR APPLICATION AS ANTAGONISTS OF GLUTAMAT METABOTROPIC RECEPTOR
|
SE0400850D0
(en)
|
2004-03-30 |
2004-03-31 |
Astrazeneca Ab |
Novel Compounds
|
JP4675959B2
(en)
|
2004-07-27 |
2011-04-27 |
エフ.ホフマン−ラ ロシュ アーゲー |
Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors
|
CN1315810C
(en)
|
2004-08-30 |
2007-05-16 |
北京理工大学 |
Piperazine-bridged tacrine binary derivatives and synthesis method thereof
|
HN2005000795A
(en)
|
2004-10-15 |
2010-08-19 |
Aventis Pharma Inc |
PYRIMIDINS AS ANTAGONISTS OF PROSTAGLANDINA D2 RECEPTOR
|
JP2008517915A
(en)
|
2004-10-22 |
2008-05-29 |
メルク エンド カムパニー インコーポレーテッド |
2- (Aryl) azacyclylmethylcarboxylates, sulfonates, phosphonates, phosphinates and heterocycles as S1P receptor agonists
|
WO2006068199A1
(en)
|
2004-12-22 |
2006-06-29 |
Mochida Pharmaceutical Co., Ltd. |
Metabolically stable 3-oxy-1,2,4-triazole derivatives
|
DE602006014502D1
(en)
|
2005-01-14 |
2010-07-08 |
Janssen Pharmaceutica Nv |
PYRAZOLOPYRIMIDINE AS CELL CYCLE KINASE HEMMER
|
WO2006078698A1
(en)
|
2005-01-19 |
2006-07-27 |
Cengent Therapeutics, Inc. |
2-imidazolone and 2-imidazolidinone heterocyclic inhibitors of tyrosine phosphatases
|
DOP2006000018A
(en)
|
2005-01-28 |
2006-07-15 |
Lilly Co Eli |
FORMULATIONS AND DOSAGE REGIME FOR ALFA PPAR MODULATORS
|
CA2604038C
(en)
|
2005-04-12 |
2013-11-12 |
Vicore Pharma Ab |
New tricyclic angiotensin ii agonists
|
JPWO2006118219A1
(en)
|
2005-04-28 |
2008-12-18 |
株式会社デンソー |
Motor and control device thereof
|
DE102005025992A1
(en)
|
2005-06-07 |
2007-01-11 |
Lanxess Deutschland Gmbh |
Process for the preparation of substituted azoles
|
WO2007019397A2
(en)
|
2005-08-05 |
2007-02-15 |
Genelabs Technologies, Inc. |
6-membered aryl and heteroaryl derivatives for the treatment of hepatitis c virus
|
AU2006306991A1
(en)
|
2005-10-28 |
2007-05-03 |
Takeda Pharmaceutical Company Limited |
Heterocyclic amide compound and use thereof
|
EP1963329B1
(en)
|
2005-11-30 |
2013-01-23 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-met and uses thereof
|
DE102006003444A1
(en)
|
2006-01-25 |
2007-07-26 |
Lanxess Deutschland Gmbh |
Method for iodinating substituted azole compound and acid addition compound by converting substituted 1H-triazoles compound, with an oxidizing agent and elementary iodine and/or iodine compound in presence of a solvent or its mixture
|
GB2435829A
(en)
|
2006-03-09 |
2007-09-12 |
Del Dr Esteve S A Spain Lab |
Pyrimidinyl-2-piperazine compounds for use in disorders related to food intake
|
GB2435828A
(en)
|
2006-03-09 |
2007-09-12 |
Del Dr Esteve S A Spain Lab |
Use of substituted phenyl-piperazine compounds for treatment of food related disorders
|
GB2435827A
(en)
|
2006-03-09 |
2007-09-12 |
Del Dr Esteve S A Spain Lab |
Use of substituted piperazine compounds for the treatment of food related disorders
|
US7674811B2
(en)
|
2006-03-14 |
2010-03-09 |
Ranbaxy Laboratories Limited |
5-lipoxygenase inhibitors
|
CA2648785A1
(en)
|
2006-03-23 |
2007-09-27 |
Prolysis Ltd. |
Antibacterial agents
|
WO2007111212A1
(en)
|
2006-03-24 |
2007-10-04 |
Eisai R & D Management Co., Ltd. |
Triazolone derivative
|
DE102006023337A1
(en)
*
|
2006-05-18 |
2007-11-22 |
Merck Patent Gmbh |
Triazole derivatives II
|
CA2653222A1
(en)
*
|
2006-05-25 |
2007-12-06 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate hsp90 activity
|
DE102006032164A1
(en)
|
2006-07-12 |
2008-01-24 |
Bayer Cropscience Ag |
Substituted furyl-sulfonylamino (thio) carbonyl-triazoline (thi) one
|
US7994321B2
(en)
|
2006-08-08 |
2011-08-09 |
Hoffmann-La Roche Inc. |
Substituted thieno[3,2-C]pyridine-7-carboxylic acid derivatives
|
CA2660201C
(en)
|
2006-08-15 |
2016-05-03 |
Novartis Ag |
Organic compounds
|
US20100099725A1
(en)
|
2007-02-23 |
2010-04-22 |
Lance Allen Pfeifer |
Peroxisome proliferator activated receptor modulators
|
CN101657433A
(en)
|
2007-03-29 |
2010-02-24 |
弗·哈夫曼-拉罗切有限公司 |
Non-nucleoside reverse transcriptase inhibitors
|
CA2683948A1
(en)
|
2007-04-20 |
2008-10-30 |
Merck Frosst Canada Ltd. |
Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
JP5671336B2
(en)
|
2007-05-08 |
2015-02-18 |
バーナム インスティテュート フォー メディカル リサーチ |
Tissue non-specific alkaline phosphatase inhibitors and their use to treat vascular calcification
|
US8252822B2
(en)
|
2007-07-17 |
2012-08-28 |
Acea Biosciences, Inc. |
Heterocyclic compounds and uses as anticancer agents
|
CA2693169C
(en)
|
2007-07-19 |
2016-01-12 |
Metabolex, Inc. |
N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
|
CN101827828B
(en)
|
2007-08-07 |
2013-02-27 |
普罗萨里克斯有限公司 |
1, 2, 4 -triazole derivatives as serotonergic modulators
|
WO2009052078A1
(en)
|
2007-10-19 |
2009-04-23 |
Boehringer Ingelheim International Gmbh |
Ccr10 antagonists
|
BRPI0822061A2
(en)
|
2007-12-10 |
2015-06-23 |
7Tm Pharma As |
Cannabinoid Receptor Modulators
|
US20090281089A1
(en)
|
2008-04-11 |
2009-11-12 |
Genentech, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
SI2291080T1
(en)
|
2008-05-14 |
2015-11-30 |
The Scripps Research Institute |
Novel modulators of sphingosine phosphate receptors
|
ES2423793T3
(en)
|
2008-05-26 |
2013-09-24 |
Genfit |
PPAR agonist compounds, preparation and uses for the treatment of diabetes and / or dyslipidemias
|
GB0810902D0
(en)
|
2008-06-13 |
2008-07-23 |
Astex Therapeutics Ltd |
New compounds
|
US7943796B2
(en)
*
|
2008-07-31 |
2011-05-17 |
Chevron Oronise Company LLC |
Lubricating oil additive and lubricating oil composition containing same
|
CN101643451B
(en)
|
2008-08-07 |
2013-03-06 |
浙江海正药业股份有限公司 |
Peroxisome proliferator-activated receptor subtype delta agonist compound and preparation method thereof
|
JP2011231015A
(en)
|
2008-08-29 |
2011-11-17 |
Taiho Yakuhin Kogyo Kk |
Novel uracil compound having nitrogenated heterocyclic ring or salt thereof
|
MX2011004125A
(en)
|
2008-10-21 |
2011-05-19 |
Metabolex Inc |
Aryl gpr120 receptor agonists and uses thereof.
|
KR101220182B1
(en)
|
2009-02-25 |
2013-01-11 |
에스케이바이오팜 주식회사 |
Azole derivatives, composition comprising thereof and method for treating parkinson's disease using the compounmd
|
CN102725281A
(en)
|
2009-06-05 |
2012-10-10 |
奥斯陆大学医院公司 |
Azole derivatives as WTN pathway inhibitors
|
WO2011005595A2
(en)
|
2009-06-24 |
2011-01-13 |
Alios Biopharma, Inc. |
2-5a analogs and their methods of use
|
DE102009028929A1
(en)
|
2009-08-27 |
2011-07-07 |
Bayer Schering Pharma Aktiengesellschaft, 13353 |
Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and their use
|
WO2011058478A1
(en)
|
2009-11-16 |
2011-05-19 |
Pfizer Inc. |
Substituted triazolopyrimidines as pde8 inhibitors
|
US20130022629A1
(en)
|
2010-01-04 |
2013-01-24 |
Sharpe Arlene H |
Modulators of Immunoinhibitory Receptor PD-1, and Methods of Use Thereof
|
KR101169359B1
(en)
|
2010-01-29 |
2012-07-30 |
주식회사 레고켐 바이오사이언스 |
Novel Oxazolidinone derivatives with cyclic amidrazone and Pharmaceutical Compositions thereof
|
WO2011103546A1
(en)
|
2010-02-22 |
2011-08-25 |
Glaxosmithkline Llc |
Triazolones as fatty acid synthase inhibitors
|
JP6026284B2
(en)
|
2010-03-03 |
2016-11-16 |
プロビオドルグ エージー |
Inhibitors of glutaminyl cyclase
|
AU2011238616B2
(en)
|
2010-03-30 |
2016-08-04 |
Verseon Corporation |
Multisubstituted aromatic compounds as inhibitors of thrombin
|
EP2371823A1
(en)
|
2010-04-01 |
2011-10-05 |
Bayer CropScience AG |
Cyclopropyl-substituted phenylsulfonylamino(thio)carbonyltriazolinones, their production and use as herbicides and plant growth regulators
|
US8097634B2
(en)
|
2010-04-15 |
2012-01-17 |
Hoffmann-La Roche Inc. |
Azacyclic derivatives
|
PL2603514T3
(en)
|
2010-08-10 |
2019-04-30 |
Rempex Pharmaceuticals Inc |
Cyclic boronic acid ester derivatives and therapeutic uses thereof
|
US20130158063A1
(en)
|
2010-08-24 |
2013-06-20 |
Georgetown University |
Compounds, Compositions and Methods Related to PPAR Antagonists
|
US20130172384A1
(en)
*
|
2010-09-17 |
2013-07-04 |
Glaxosmithkline Intellectual Property Development Limited |
Fatty acid synthase inhibitors
|
JP5847533B2
(en)
|
2010-10-19 |
2016-01-27 |
田辺三菱製薬株式会社 |
Novel thyroid hormone beta receptor agonist
|
WO2012058531A2
(en)
|
2010-10-29 |
2012-05-03 |
North Carolina State University |
Modulation of response regulators by imidazole derivatives
|
US9505728B2
(en)
|
2012-03-09 |
2016-11-29 |
Inception 2, Inc. |
Triazolone compounds and uses thereof
|
CA2894281C
(en)
|
2012-12-20 |
2021-04-20 |
Inception 2, Inc. |
Triazolone compounds and uses thereof
|
PE20160880A1
(en)
|
2013-09-06 |
2016-09-22 |
Inception 2 Inc |
TRIAZOLONE COMPOUNDS AND USES OF THEM
|